A breakthrough by Quebec researchers offers some initial hope to patients suffering from a disease that is rare worldwide, but more common in the Saguenay-Lac-Saint-Jean region. Myotonic dystrophy type 1 (DM1) affects about one in 8,000 people worldwide, but about one in 500 in Saguenay-Lac-Saint-Jean due to the founder effect.